losartan has been researched along with trandolapril in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 23 (69.70) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Campan, M; Costerousse, O; Desgranges, C; Gadeau, AP; Millet, D | 1 |
| Brecher, P; Chobanian, AV; Crawford, DC; Farivar, RS | 1 |
| Miyazaki, M; Okunishi, H; Song, K; Takai, S; Tanaka, T | 1 |
| Ehmke, H; Kirchengast, M; Münter, K | 1 |
| Fornes, P; Gervais, M; Giudicelli, JF; Richer, C | 1 |
| Genès, N; Herpin, D; Ragot, S; Vaur, L | 1 |
| Fogari, E; Fogari, R; Malamani, G; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Armenteros, S; Fernández González, R; Garrido, J; Goicolea, I; Martínez, JM; Moreno Carretero, E; Piniés, J | 1 |
| Ideura, T; Kayano, T; Morita, H; Nakao, N; Takada, M; Yoshimura, A | 1 |
| Böger, C; Fischereder, M; Krämer, BK; Krüger, B; Stubanus, M | 1 |
| Choukroun, G; Fournier, A; Makdassi, R; Mansour, J; Presne, C | 1 |
| Doggrell, SA | 1 |
| Nesto, RW | 1 |
| Takamitsu, Y | 1 |
| Kanno, Y; Suzuki, H | 1 |
| Hunsicker, LG | 1 |
| Brehm, BR; Risler, T; Rodemann, HP; Sauter, G; Wolf, SC | 1 |
| Komuro, I; Kuwabara, Y | 1 |
| Furukawa, T; Hayashi, M; Homma, K; Ichihara, A; Kaneshiro, Y; Kanno, Y; Saruta, T; Takemitsu, T; Takenaka, T; Yoshizawa, M | 1 |
| Brehm, BR; Risler, T; Sauter, G; Wolf, SC | 1 |
| Wolf, G | 1 |
| Coleman, CI; Kalus, JS; White, CM | 1 |
| Kanno, Y; Shoda, J; Suzuki, H | 1 |
| Bacher, P; Bakris, G; Champion, A; Molitch, M; Sarafidis, P; Sowers, JR; Zhou, Q | 1 |
| De la Iglesia Iñigo, S; Gómez-Casares, MT; Lemes Castellano, A; López Brito, J; López-Jorge, CE; Martín Cabrera, P; Molero Labarta, T; Suárez Cabrera, A | 1 |
| Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
| Certíková Chábová, V; Červenka, L; Husková, Z; Kramer, HJ; Kujal, P; Skaroupková, P; Tesař, V; Vaněčková, I; Vaňourková, Z; Vernerová, Z | 1 |
| Cervenka, L; Kopkan, L; Kratky, V; Sykora, M; Szeiffova Bacova, B; Tribulova, N | 1 |
10 review(s) available for losartan and trandolapril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Creatinine; Drug Therapy, Combination; Endpoint Determination; Humans; Indoles; Kidney Failure, Chronic; Losartan; Renin-Angiotensin System | 2003 |
Pharmacological treatment and prevention of heart failure in the diabetic patient.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Angiopathies; Heart Failure; Humans; Indoles; Losartan; Risk Factors | 2004 |
[Therapeutic strategy for patients with stable-stage chronic kidney failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diet, Protein-Restricted; Disease Progression; Humans; Hypokalemia; Indoles; Japan; Kidney Failure, Chronic; Losartan; Renal Dialysis | 2004 |
[Diagnosis of and therapy for renal hypertension].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hypertension, Renal; Indoles; Losartan; Nephrosclerosis | 2004 |
Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Nephropathies; Drug Therapy, Combination; Endpoint Determination; Humans; Hypertension; Indoles; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2004 |
[Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Lisinopril; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2005 |
[The renin-angiotensin-aldosterone system -- more complex as previously thought].
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases | 2005 |
The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Enalapril; Humans; Indoles; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Secondary Prevention; Tetrazoles; Valine; Valsartan | 2006 |
7 trial(s) available for losartan and trandolapril
| Article | Year |
|---|---|
Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Feasibility Studies; Female; Humans; Hypertension; Indoles; Losartan; Male; Middle Aged; Observer Variation; Reproducibility of Results; Self Care | 2000 |
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Fibrinolysis; Humans; Hypertension; Indoles; Insulin; Insulin Resistance; Lipids; Losartan; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Sensitivity and Specificity; Women's Health | 2001 |
[Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lipids; Losartan; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Vasodilator Agents; Verapamil | 2002 |
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Therapy, Combination; Female; Humans; Indoles; Kidney Diseases; Kidney Function Tests; Losartan; Male; Middle Aged; Treatment Outcome | 2003 |
Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients.
Topics: Aged; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Dinoprost; Drug Therapy, Combination; Erythropoietin; Female; Follow-Up Studies; Hematocrit; Humans; Hyperlipidemias; Indoles; Kidney Failure, Chronic; Lipids; Lipoproteins; Lipoproteins, LDL; Losartan; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome; Vascular Resistance | 2005 |
A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Indoles; Losartan; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Tetrazoles | 2006 |
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
Topics: Analysis of Variance; Chi-Square Distribution; Diabetes Mellitus; Diuretics; Female; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Metabolic Syndrome; Middle Aged; Renin-Angiotensin System; Verapamil | 2008 |
16 other study(ies) available for losartan and trandolapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Biphenyl Compounds; Captopril; Cells, Cultured; DNA; Imidazoles; Indoles; Losartan; Muscle, Smooth, Vascular; Oligopeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred WKY; RNA; Tetrazoles | 1992 |
Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blotting, Northern; Fibrosis; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Phenylephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; Tetrazoles | 1995 |
Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Topics: Administration, Oral; Analgesics; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Enalapril; Imidazoles; Indoles; Losartan; Male; Mice; Naloxone; Pain Measurement; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Tetrazoles | 1996 |
Maintenance of blood pressure in normotensive dogs by endothelin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Drug Synergism; Endothelin Receptor Antagonists; Endothelins; Indoles; Losartan; Male; Nitric Oxide; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Reference Values | 1999 |
Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Coronary Circulation; Cyclic GMP; Heart Failure; Hemodynamics; Indoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
The COOPERATE trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Losartan; Renal Dialysis | 2003 |
The COOPERATE trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Diuretics; Dose-Response Relationship, Drug; Humans; Indoles; Kidney Diseases; Losartan; Sodium | 2003 |
Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Becaplermin; Cell Division; Indoles; Kinetics; Losartan; Male; Muscle, Smooth, Vascular; Nephrectomy; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Indoles; Kidney Failure, Chronic; Losartan; Male; Muscle, Smooth, Vascular; Nephrectomy; Probability; Rats; Rats, Sprague-Dawley; Risk Factors; Sensitivity and Specificity; Uremia | 2005 |
Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Blotting, Northern; Blotting, Western; Captopril; Cell Proliferation; Genes, myc; Humans; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Losartan; Polymerase Chain Reaction | 2009 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |
Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Disease Models, Animal; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Hypertension, Renal; Indoles; Kidney; Losartan; Male; Nephrectomy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Renal Insufficiency, Chronic; Renin-Angiotensin System; Survival Analysis; Treatment Outcome | 2012 |
The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats.
Topics: Animals; Blood Pressure; Connexin 43; Extracellular Matrix; Fistula; Heart Failure; Hypertension; Losartan; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin | 2023 |